Showing results (101-110 of 645) with videos related to
Sort By:
Pageof 65
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2020
Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin LymphomaBruce D Cheson, Franck Morschhauser, Peter MartinDisaster Medicine and Public Health Preparedness|September 8, 2023
Communication in Sudden-Onset Major Incidents: Patterns and Challenges-Scoping ReviewPeter Martin Hansen, Søren Mikkelsen, Marius RehnGround Water|June 4, 2011
Hybrid-optimization algorithm for the management of a conjunctive-use project and well field designYung-Chia Chiu, Tracy Nishikawa, Peter MartinJournal of Clinical Neuromuscular Disease|August 25, 2015
Correlation of Changes in Gait Parameters, With Phenotype, Outcome Measures, and Electrodiagnostic Abnormalities in a Patient With Anti-MAG Neuropathy After Exacerbation and ImprovementMary L Vo, Peter Martin, Norman LatovClinical & Experimental Ophthalmology|April 22, 2006
Idiopathic orbital inflammation with sclerosing mesenteritis: a new association?Vidushi Sharma, Peter Martin, Veli-Matti MarjoniemiJournal of Clinical Medicine|October 16, 2024
Streamlined Preoperative Iron Deficiency Screening and IV Treatment for Colorectal Cancer Patients beyond Clinical TrialsCaroline Erichsen, Victoria Rosberg, Peter-Martin KrarupAmerican Journal of Hematology|February 3, 2015
Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)Kami Maddocks, Lai Wei, Darlene Rozewski, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 26, 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic MalignancyAshley E Rosko, Sarah Wall, Robert Baiocchi, et al.Blood Advances|April 4, 2023
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphomaTycel J Phillips, David Bond, Radihka Takiar, et al.Journal of Clinical Medicine|April 3, 2021
Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future DirectionsDavid A Bond, Peter Martin, Kami J MaddocksPageof 65